In a study of whole genome sequencing data of pancreatic cancer patients with pathogenic variants of BRCA1/2 or PALB2, signature 3 mutations, and genomic instability were correlated with platinum response [15]. This evidence concerns the gene PALB2 and familial pancreatic carcinoma.